Ambry Genetics-Led Research Collaboration Clears Path to Understanding Optic Atrophy in Mitochondrial Disease

Ambry Genetics Corporation demonstrated that defects in a gene called FDXR are associated with optic atrophy, or loss of vision, in some patients with mitochondrial disease. The company collaborated with a research laboratory and a children’s medical center to find the disease-causing mechanism and move…